Literature DB >> 28515320

Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).

Felix A Deuss1,2,3, Benjamin S Gully1,2,3, Jamie Rossjohn4,2,3,5, Richard Berry6,2,3.   

Abstract

T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on the surface of natural killer (NK) cells. TIGIT recognizes nectin and nectin-like adhesion molecules and thus plays a critical role in the innate immune response to malignant transformation. Although the TIGIT nectin-like protein-5 (necl-5) interaction is well understood, how TIGIT engages nectin-2, a receptor that is broadly over-expressed in breast and ovarian cancer, remains unknown. Here, we show that TIGIT bound to the immunoglobulin domain of nectin-2 that is most distal from the membrane with an affinity of 6 μm, which was moderately lower than the affinity observed for the TIGIT/necl-5 interaction (3.2 μm). The TIGIT/nectin-2 binding disrupted pre-assembled nectin-2 oligomers, suggesting that receptor-ligand and ligand-ligand associations are mutually exclusive events. Indeed, the crystal structure of TIGIT bound to the first immunoglobulin domain of nectin-2 indicated that the receptor and ligand dock using the same molecular surface and a conserved "lock and key" binding motifs previously observed to mediate nectin/nectin homotypic interactions as well as TIGIT/necl-5 recognition. Using a mutagenesis approach, we dissected the energetic basis for the TIGIT/nectin-2 interaction and revealed that an "aromatic key" of nectin-2 is critical for this interaction, whereas variations in the lock were tolerated. Moreover, we found that the C-C' loop of the ligand dictates the TIGIT binding hierarchy. Altogether, these findings broaden our understanding of nectin/nectin receptor interactions and have implications for better understanding the molecular basis for autoimmune disease and cancer.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell adhesion; immunoglobulin fold; innate immunity; natural killer cells (NK cells); protein structure

Mesh:

Substances:

Year:  2017        PMID: 28515320      PMCID: PMC5500806          DOI: 10.1074/jbc.M117.786483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering.

Authors:  Katharina F Stengel; Kristin Harden-Bowles; Xin Yu; Lionel Rouge; Jianping Yin; Laëtitia Comps-Agrar; Christian Wiesmann; J Fernando Bazan; Dan L Eaton; Jane L Grogan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

Review 2.  Killer cell inhibitory receptors: diversity, specificity, and function.

Authors:  E O Long; D N Burshtyn; W P Clark; M Peruzzi; S Rajagopalan; S Rojo; N Wagtmann; C C Winter
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

Review 3.  The Ly49 natural killer cell receptors: a versatile tool for viral self-discrimination.

Authors:  Richard Berry; Jamie Rossjohn; Andrew G Brooks
Journal:  Immunol Cell Biol       Date:  2014-01-14       Impact factor: 5.126

4.  A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family.

Authors:  Oscar A Aguilar; Richard Berry; Mir Munir A Rahim; Johanna J Reichel; Branka Popović; Miho Tanaka; Zhihui Fu; Gautham R Balaji; Timothy N H Lau; Megan M Tu; Christina L Kirkham; Ahmad Bakur Mahmoud; Aruz Mesci; Astrid Krmpotić; David S J Allan; Andrew P Makrigiannis; Stipan Jonjić; Jamie Rossjohn; James R Carlyle
Journal:  Cell       Date:  2017-03-23       Impact factor: 41.582

5.  Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Authors:  Daniel M Andrews; Lucy C Sullivan; Nikola Baschuk; Christopher J Chan; Richard Berry; Claire L Cotterell; Jie Lin; Heloise Halse; Sally V Watt; Jennifer Poursine-Laurent; Chyung-Ru Wang; Anthony A Scalzo; Wayne M Yokoyama; Jamie Rossjohn; Andrew G Brooks; Mark J Smyth
Journal:  Nat Immunol       Date:  2012-11-11       Impact factor: 25.606

Review 6.  Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules.

Authors:  J C Boyington; A G Brooks; P D Sun
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

7.  Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

Authors:  Noa Stanietsky; Tihana Lenac Rovis; Ariella Glasner; Einat Seidel; Pinchas Tsukerman; Rachel Yamin; Jonatan Enk; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

8.  Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141.

Authors:  Peter Tomasec; Eddie C Y Wang; Andrew J Davison; Borivoj Vojtesek; Melanie Armstrong; Cora Griffin; Brian P McSharry; Rebecca J Morris; Sian Llewellyn-Lacey; Carole Rickards; Akio Nomoto; Christian Sinzger; Gavin W G Wilkinson
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

9.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.

Authors:  A G Brooks; P E Posch; C J Scorzelli; F Borrego; J E Coligan
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  27 in total

Review 1.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Structure of the heterophilic interaction between the nectin-like 4 and nectin-like 1 molecules.

Authors:  Xiao Liu; Tai An; Dongdong Li; Zheng Fan; Pan Xiang; Chen Li; Wenyi Ju; Jianing Li; Gen Hu; Bo Qin; Bin Yin; Justyna Aleksandra Wojdyla; Meitian Wang; Jiangang Yuan; Boqin Qiang; Pengcheng Shu; Sheng Cui; Xiaozhong Peng
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-23       Impact factor: 11.205

3.  PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function.

Authors:  Sarah Whelan; Eran Ophir; Maya F Kotturi; Ofer Levy; Sudipto Ganguly; Ling Leung; Ilan Vaknin; Sandeep Kumar; Liat Dassa; Kyle Hansen; David Bernados; Benjamin Murter; Abha Soni; Janis M Taube; Amanda Nickles Fader; Tian-Li Wang; Ie-Ming Shih; Mark White; Drew M Pardoll; Spencer C Liang
Journal:  Cancer Immunol Res       Date:  2019-01-18       Impact factor: 11.151

4.  Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1.

Authors:  Felix A Deuss; Gabrielle M Watson; Katharine J Goodall; Isobel Leece; Sayantani Chatterjee; Zhihui Fu; Morten Thaysen-Andersen; Daniel M Andrews; Jamie Rossjohn; Richard Berry
Journal:  J Biol Chem       Date:  2019-06-28       Impact factor: 5.157

Review 5.  Heart failure in cancer: role of checkpoint inhibitors.

Authors:  Murilo Delgobo; Stefan Frantz
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.

Authors:  Han Wang; Jianxun Qi; Shuijun Zhang; Yan Li; Shuguang Tan; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

7.  DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.

Authors:  Kazuki Sato; Yumi Yamashita-Kanemaru; Fumie Abe; Rikito Murata; Yuho Nakamura-Shinya; Kazumasa Kanemaru; Masafumi Muratani; André Veillette; Motohito Goto; Mamoru Ito; Akira Shibuya; Kazuko Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

8.  Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD).

Authors:  S Battella; S Oliva; L Franchitti; R La Scaleia; A Soriani; S Isoldi; C Capuano; C Pighi; S Morrone; R Galandrini; A Santoni; G Palmieri
Journal:  Mucosal Immunol       Date:  2019-10-03       Impact factor: 7.313

Review 9.  The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy.

Authors:  Bonnie L Russell; Selisha A Sooklal; Sibusiso T Malindisa; Lembelani Jonathan Daka; Monde Ntwasa
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

Review 10.  Collective metastasis: coordinating the multicellular voyage.

Authors:  Emma Wrenn; Yin Huang; Kevin Cheung
Journal:  Clin Exp Metastasis       Date:  2021-07-12       Impact factor: 4.510

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.